Search Results - "Grego, Elisabetta"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Adjuvant chemotherapy in resected bile duct cancer: A systematic review and meta-analysis of randomized trials by Messina, Carlo, Merz, Valeria, Frisinghelli, Michela, Trentin, Chiara, Grego, Elisabetta, Veccia, Antonello, Salati, Massimiliano, Messina, Marco, Carnaghi, Carlo, Caffo, Orazio

    Published in Critical reviews in oncology/hematology (01-11-2019)
    “…•The role of adjuvant chemotherapy for biliary tract cancers is still unclear.•We performed a meta-analysis to assess benefit and risks of adjuvant…”
    Get full text
    Journal Article
  2. 2

    Myositis and myasthenia during nivolumab administration for advanced lung cancer: a case report and review of the literature by Veccia, Antonello, Kinspergher, Stefania, Grego, Elisabetta, Peterlana, Dimitri, Berti, Alvise, Tranquillini, Enzo, Caffo, Orazio

    Published in Anti-cancer drugs (01-06-2020)
    “…The immunotherapy significantly improved survival of non-small cell lung cancer patients, but it may cause immune-related adverse events, which are severe in…”
    Get full text
    Journal Article
  3. 3

    Pathogenesis, Clinical Manifestations and Management of Immune Checkpoint Inhibitors Toxicity by Inno, Alessandro, Metro, Giulio, Bironzo, Paolo, Grimaldi, Antonio M., Grego, Elisabetta, Di Nunno, Vincenzo, Picasso, Virginia, Massari, Francesco, Gori, Stefania

    Published in Tumori (01-09-2017)
    “…Immune checkpoint inhibitors have emerged as an effective treatment for several tumor types and their use in clinical practice is expected to further increase…”
    Get full text
    Book Review Journal Article
  4. 4

    The development of PARP as a successful target for cancer therapy by Ferrara, Roberto, Simionato, Francesca, Ciccarese, Chiara, Grego, Elisabetta, Cingarlini, Sara, Iacovelli, Roberto, Bria, Emilio, Tortora, Giampaolo, Melisi, Davide

    Published in Expert review of anticancer therapy (01-02-2018)
    “…Introduction: PARP1 and BRCA genes are essential genome caretakers and their interaction has been the first example of synthetic lethality, a genetic concept…”
    Get full text
    Journal Article
  5. 5

    Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms by Pulvirenti, Alessandra, Raj, Nitya, Cingarlini, Sara, Pea, Antonio, Tang, Laura H., Luchini, Claudio, Chou, Joanne F., Grego, Elisabetta, Marinova, Ioana, Capanu, Marinela, Landoni, Luca, Scarpa, Aldo, Allen, Peter J., Klimstra, David S., Reidy-Lagunes, Diane L.

    Published in Pancreas (01-02-2021)
    “…Pancreatic neuroendocrine neoplasms include well-differentiated tumors (PanNETs) and poorly differentiated carcinomas (PanNECs). Previous reports suggested a…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment by D'Onofrio, Mirko, Cingarlini, Sara, Ortolani, Silvia, Crosara, Stefano, DE Robertis, Riccardo, Vallerio, Paola, Grego, Elisabetta, Ciaravino, Valentina, Ruzzenente, Andrea, Landoni, Luca, Scarpa, Aldo, Bassi, Claudio, Tortora, Giampaolo

    Published in Anticancer research (01-03-2017)
    “…To evaluate modifications of perfusional parameters assessed by perfusion computed tomography (P-CT) of liver metastases (LM) from pancreatic neuroendocrine…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report by Ciccarese, Chiara, Ferrara, Roberto, Fantinel, Emanuela, Zecchetto, Camilla, Simionato, Francesca, Grego, Elisabetta, Ortolani, Silvia, Caccese, Mario, Bimbatti, Davide, Cingarlini, Sara, Brunelli, Matteo, Andreini, Angelo, Tortora, Giampaolo, Massari, Francesco

    Published in Future science OA (01-11-2015)
    “…Hemophagocytic lymphohistiocytosis (HLH) is a syndrome characterized by severe hyperinflammation due to an overwhelming ineffective immune response to…”
    Get full text
    Journal Article
  10. 10